Reversal of topical antiglaucoma medication effects on the conjunctiva

Archives of Ophthalmology
D BroadwayR Hitchings

Abstract

To determine whether the adverse effects of antiglaucoma medications could be reversed before filtration surgery, potentially reducing the risk of subsequent failure. One month before surgery, 30 patients who were receiving multiple antiglaucoma medications underwent an inferior bulbar conjunctival biopsy, ceased using sympathomimetic drops, and began treatment with topical corticosteroid, (1% fluorometholone four times daily). At the time of surgery two conjunctival biopsy specimens were obtained, one from the operation site (superior bulbar region), and one from the inferior bulbar region. The biopsy specimens were quantitatively analyzed by light microscopy. In addition, the outcome of first trabeculectomy for 16 of these patients was compared with that of 16 matched patients who had not undergone an altered preoperative regimen of topical therapy. During a 1-month period a notable decrease occurred in the number of fibroblasts and inflammatory cells throughout the conjunctiva. Inferior bulbar conjunctiva was found to be representative of superior bulbar conjunctiva with respect to these changes. Furthermore, evidence comparing the matched patients suggested that the altered preoperative regimen may have improved the success...Continue Reading

Citations

Jun 7, 2013·Middle East African Journal of Ophthalmology·Girum W Gessesse, Karim F Damji
Nov 28, 2012·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·H Thieme, K K van der Velden
Dec 1, 2014·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Paul E Rafuse
Dec 3, 2014·Journal français d'ophtalmologie·F AptelP Denis
Aug 20, 2002·The British Journal of Ophthalmology·P HamardC Baudouin
Aug 26, 1998·Australian and New Zealand Journal of Ophthalmology·A A McNab
Sep 9, 2011·Journal of Ophthalmic Inflammation and Infection·Carsten HeinzArnd Heiligenhaus
Aug 23, 2006·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·T KlinkG Schlunck
Oct 4, 2011·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·J Stürmer
Dec 18, 2013·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·H ThiemeC Schuart
Feb 13, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Wei-Cherng HsuHenry Shen-Lih Chen
May 29, 2007·Advances in Therapy·Detlev SpiegelRichard A Hill
Oct 17, 2012·Survey of Ophthalmology·Leonard K SeiboldMalik Y Kahook
Aug 28, 2012·Journal français d'ophtalmologie·S MilazzoE Hachet
Mar 23, 2010·Journal français d'ophtalmologie·A Labbé, C Baudouin
Dec 18, 2015·Experimental Eye Research·Günther SchlunckFranz Grehn
Mar 29, 2011·Annales pharmaceutiques françaises·H Chibret
Jul 5, 2001·American Journal of Ophthalmology·C E ParcD O Hodge
Jan 31, 2014·Ocular Immunology and Inflammation·João Marcello FurtadoMaria de Lourdes Veronese Rodrigues
Dec 3, 2014·Archivos de la Sociedad Española de Oftalmología·I Rodríguez UñaUNKNOWN Grupo Español para el Consenso acerca del Manejo Farmacológico Perioperatorio en pacientes con glaucoma
Jan 1, 2014·Orvosi hetilap·Gábor Holló
Oct 16, 2016·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·A G M JünemannB Hohberger
Jul 10, 2001·Journal of Glaucoma·D C Broadway, L P Chang
Apr 17, 2004·International Ophthalmology Clinics·Sean-Paul A AtreidesAdam C Reynolds
Oct 12, 2000·Eye·M F CordeiroP T Khaw
Mar 22, 2003·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Robert M Feldman
Jul 6, 2018·The British Journal of Ophthalmology·David W StevenKin Sheng Lim
Mar 20, 2009·Journal of Glaucoma·Maria de Lourdes Veronese RodriguesEdson Garcia Soares
Oct 10, 2015·European Journal of Ophthalmology·Leiser FrancoLeopoldo Magacho
Mar 14, 2013·European Journal of Ophthalmology·Ingeborg StalmansAlain Bron
Oct 12, 2014·Journal of Glaucoma·Joanna Wasielica-PoslednikNorbert Pfeiffer
Feb 27, 2015·Journal of Glaucoma·Linda ZhengDavid Wechsler
Dec 3, 2020·Journal of Glaucoma·Adam MuzychukMona Harissi-Dagher
Jan 23, 2021·Expert Opinion on Drug Safety·Anastasios G KonstasChristophe Baudouin
Sep 1, 2012·Journal of Current Glaucoma Practice·Y Louati, T Shaarawy
Nov 13, 2020·Journal of Cataract and Refractive Surgery·Shikha GuptaViney Gupta
Jun 6, 2006·Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye·Christina A BrunoSayoko E Moroi
May 28, 2016·Journal of Current Glaucoma Practice·Tom Eke
May 15, 2003·Survey of Ophthalmology·Paul J Lama, Robert D Fechtner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.